Coronary atherosclerotic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Consistent with the diagnostic criteria for stable coronary heart disease. (2) over 18 years of age.
Exclusion criteria
Exclusion criteria: (1) Pregnant or lactating women; (2) Patients who have received clinical trials of other new drugs within the last 3 months; (3) a combination of psychiatric alcoholic and/or psychoactive substance abusers and dependent persons; (4) Type 1 diabetes or type 2 diabetes with poor blood glucose control (fasting blood glucose >11mmol/L) or complications (kidney disease peripheral neuropathy); (5) Gastrointestinal diseases or gastrointestinal surgery may affect drug absorption and other serious diseases of the digestive system; (6) Concurrent with the following organ damage or disease: renal insufficiency (blood creatinine greater than the upper limit of normal); Abnormal liver function (ALT and AST greater than 1.5 times the upper limit of normal); Active recurrent digestive ulcers or other bleeding risk diseases; Combined with malignant tumors hematological diseases or other serious or progressive diseases of the system.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrent myocardial infarction;Revascularization;Cerebral apoplexy;Cardiovascular death; | — |
Secondary
| Measure | Time frame |
|---|---|
| ICU transfer rate;Readmission time;Left ventricular systolic and diastolic function; | — |
Countries
China
Contacts
Shandong University of Chinese Medicine